Evaluation of the effect of Pistacia atlantica oleoresin on fasting blood sugar in patients with type 2 diabetes and its relationship with lipid profile and blood pressure A randomized, single-blind, placebo-controlled trial

Gorgan University of Medical Sciences0 个研究点目标入组 42 人开始时间: 待定最近更新: 2022年4月4日

试验速览

暂无简介。

•The patient's desire to enter the study
•Age between 30-64 years, whose definitive diagnosis of diabetes has been made by performing two FBS tests more than 126 and the approval of the relevant specialist.
•Patients with a history of type 2 diabetes are diagnosed less than two years after the onset of the disease and use at least one standard oral medication (metformin tablets) for initial control of the disease.
•HbA1c is more equal to 8% and less than 9%.

•blood sugar more than 300 and HbA1c is more equal to 9% .
•Have indications for starting insulin and other injectable therapy.
•Patients treated with insulin
•Moderate to severe renal insufficiency (GFR less than 45 or albuminuria more than 300 mg)
•Liver failure (diagnosis by an internal medicine specialist or gastroenterologist based on bilirubin, albumin and liver enzymes)
•Class 3 and 4 heart failure
•Diabetic retinopathy
•Serious medical illness
•Simultaneous infectious diseases including pulmonary tuberculosis, diabetic foot ulcers and ...
•High blood pressure (systolic above 160 or diastolic above 100 mm Hg) or need to take more than three antihypertensive drugs
•Women who decide to get pregnant
•Pregnant women and lactating women

发起方

Gorgan University of Medical Sciences